|
Market Closed -
Bombay S.E.
06:02:22 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 123.60 INR | -1.59% |
|
-9.52% | +200.95% |
| Market Cap | 67.73B 714M 634M 588M 535M 1.01B 1.03B 7.07B 2.77B 35.34B 2.68B 2.62B 113B | P/E 2025 |
21.8x | P/E 2026 | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 69.27B 730M 649M 601M 547M 1.03B 1.05B 7.23B 2.83B 36.15B 2.74B 2.68B 115B | EV / Sales 2025 |
1.45x | EV / Sales 2026 | 1.11x |
| Free-Float |
57.31% | Yield 2025 |
0.42% | Yield 2026 | 0.59% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
NSE India S.E.
| MOREPENLAB | Delayed |
| 1 day | -1.59% | ||
| 1 week | -9.52% | ||
| Current month | -1.90% | ||
| 1 month | +16.33% | ||
| 3 months | +101.43% | ||
| 6 months | +199.49% | ||
| Current year | +200.95% |
| 1 week | 117.7 |  | 133.7 |
| 1 month | 112.7 | | 150.8 |
| Current year | 33.44 | | 150.8 |
| 1 year | 33.44 | | 150.8 |
| 3 years | 31.31 | | 150.8 |
| 5 years | 23.65 | | 150.8 |
| 10 years | 7.21 | | 150.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.59% | -9.52% | +157.02% | +247.88% | 727M | |
| +0.43% | +7.48% | +52.08% | +106.34% | 1,116B | |
| +0.90% | -0.36% | +33.68% | +62.93% | 610B | |
| +0.71% | +4.77% | +26.17% | +92.90% | 501B | |
| +0.52% | +2.51% | +73.52% | +40.32% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +6.15% | +45.46% | +52.23% | 235B | |
| -0.75% | +6.18% | +32.03% | +101.15% | 195B | |
| Average | -0.14% | +3.93% | +47.17% | +80.83% | 393.05B | |
| Weighted average by Cap. | +0.30% | +4.93% | +38.85% | +72.19% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.12B 191M 170M 157M 143M 270M 274M 1.89B 741M 9.45B 716M 701M 30.14B | 18.06B 190M 169M 157M 143M 269M 273M 1.88B 739M 9.42B 714M 699M 30.04B |
| Net income | 1.18B 12.44M 11.05M 10.25M 9.32M 17.59M 17.87M 123M 48.29M 616M 46.67M 45.68M 1.96B | 949M 10M 8.89M 8.24M 7.49M 14.14M 14.37M 99M 38.82M 495M 37.52M 36.72M 1.58B |
| Net Debt | -928K -9.78K -8.69K -8.06K -7.33K -13.83K -14.05K -96.83K -37.97K -484K -36.7K -35.92K -1.54M | 1.54B 16.2M 14.4M 13.35M 12.15M 22.92M 23.29M 160M 62.92M 803M 60.82M 59.52M 2.56B |
Employees
1,919
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | ₹123.60 | -1.59% | 237,272 |
| 26-10-15 | ₹125.60 | -1.76% | 378,499 |
| 26-10-14 | ₹127.85 | +4.97% | 534,160 |
| 26-10-13 | ₹121.80 | -4.77% | 880,695 |
| 26-10-12 | ₹127.90 | -1.43% | 604,330 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
